scispace - formally typeset
C

Chengbiao Lu

Researcher at Xinxiang Medical University

Publications -  35
Citations -  521

Chengbiao Lu is an academic researcher from Xinxiang Medical University. The author has contributed to research in topics: Hippocampal formation & Hippocampus. The author has an hindex of 10, co-authored 31 publications receiving 315 citations. Previous affiliations of Chengbiao Lu include McGovern Institute for Brain Research & Yangtze University.

Papers
More filters
Journal ArticleDOI

Current understanding of metal ions in the pathogenesis of Alzheimer’s disease

TL;DR: Adjusting metal balance by supplementing or chelating the metal ions may be potential in ameliorating AD pathologies, which provides new research directions for AD treatment.
Journal ArticleDOI

Relative power and coherence of EEG series are related to amnestic mild cognitive impairment in diabetes

TL;DR: The proposed indexes from rsEEG recordings could be employed to track cognitive function of diabetic patients and also to help in the diagnosis of those who develop aMCI.
Journal ArticleDOI

Transcranial Direct Current Stimulation Ameliorates Behavioral Deficits and Reduces Oxidative Stress in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Mouse Model of Parkinson's Disease.

TL;DR: The present study was designed to investigate the effects of transcranial direct current stimulation (tDCS) on the oxidative stress in a mouse model of PD induced by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP).
Journal ArticleDOI

Resting-state EEG coupling analysis of amnestic mild cognitive impairment with type 2 diabetes mellitus by using permutation conditional mutual information.

TL;DR: The results showed that the coupling strength or directionality of EEG signals calculated by PCMI might be used as a biomarker in distinguishing the aMCI from NC with T2DM.
Journal ArticleDOI

Quetiapine mitigates the ethanol-induced oxidative stress in brain tissue, but not in the liver, of the rat

TL;DR: Protection on the antioxidants catalase and total superoxide dismutase and on the TAC may explain the clinical observations that quetiapine reduced psychiatric symptoms intensity and maintained a good level of tolerability in chronic alcoholism with comorbid psychopathology.